Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. Juni 2023 04:00 ET | Quelle: AKAMPION

Thermosome Announces Participation in IMAGIO Consortium to Improve Cancer Treatment

IMAGIO consortium of clinical partners coordinated by Philips receives EUR 24 million grant from the Innovative Health Initiative (IHI) and additional funding from industry partners to support the...
08. Februar 2022 10:00 ET | Quelle: Seno Medical

Seno Medical’s Imagio® Breast Imaging System Named Science and Medical Category Finalist in 2022 Edison Awards Program

San Antonio, Texas, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Seno Medical’s Imagio® Breast Imaging System has been named a finalist in the 2022 Edison Awards competition in the Science and Medical category...
01. Dezember 2021 09:00 ET | Quelle: Seno Medical

Poster Presentation at RSNA Compares Seno Medical’s OA/US Breast Imaging with AI Decision Support to Ultrasound Alone; Finds Significantly Better Specificity to Support Clinical Decision Making Confidence.

San Antonio, TX, Dec. 01, 2021 (GLOBE NEWSWIRE) -- A study presented at the Radiological Society of North America (RSNA)’s annual meeting showed Texas-based Seno Medical Instruments, Inc. (Seno)’s...
21. Oktober 2021 11:00 ET | Quelle: Seno Medical

Seno Medical Launches CONFIDENCE Registry Study for Imagio® Breast Imaging System

San Antonio, TX, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Texas-based Seno Medical Instruments, Inc. (Seno) has launched its CONFIDENCE registry to evaluate the efficacy of imaging with...
19. Januar 2021 10:45 ET | Quelle: Seno Medical

FDA Approves Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology

San Antonio, TX, Jan. 19, 2021 (GLOBE NEWSWIRE) -- The Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has granted Texas-based Seno Medical...